Log in

HEMO HemoGenyx Pharmaceuticals Plc LSE · United Kingdom

HemoGenyx Pharmaceuticals Plc (HEMO) news

HemoGenyx Pharmaceuticals Plc is a public biotech or pharmaceutical company listed on LSE under the ticker HEMO, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest HemoGenyx Pharmaceuticals Plc news

We have not published a story on HemoGenyx Pharmaceuticals Plc yet. When there is news, it will appear here.

Questions about HemoGenyx Pharmaceuticals Plc

What is the ticker symbol of HemoGenyx Pharmaceuticals Plc?

HemoGenyx Pharmaceuticals Plc trades under the ticker HEMO on LSE.

Where is HemoGenyx Pharmaceuticals Plc listed?

HemoGenyx Pharmaceuticals Plc is listed on LSE. Our directory also records these other listings: LSX:A40WGA.

Which country or territory is HemoGenyx Pharmaceuticals Plc listed under?

Our directory records HemoGenyx Pharmaceuticals Plc under United Kingdom.

What does HemoGenyx Pharmaceuticals Plc do?

Our directory classifies HemoGenyx Pharmaceuticals Plc as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of HemoGenyx Pharmaceuticals Plc?

The ISIN recorded for HemoGenyx Pharmaceuticals Plc is GB00BQVXM815.

Does aibio.space cover HemoGenyx Pharmaceuticals Plc?

aibio.space lists HemoGenyx Pharmaceuticals Plc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to HemoGenyx Pharmaceuticals Plc?

Companies in our directory listed in the same country and business area as HemoGenyx Pharmaceuticals Plc: Oxford BioDynamics Plc, Mereo BioPharma Group, NuCana, Immunocore Holdings, Oxford BioMedica, OKYO Pharma.

Investor discussion: HemoGenyx Pharmaceuticals Plc

Members talk about HemoGenyx Pharmaceuticals Plc (HEMO). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open LSE:HEMO on TradingView.

Listing details

HemoGenyx Pharmaceuticals Plc is a public biotech or pharmaceutical company listed on LSE under the ticker HEMO, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
HemoGenyx Pharmaceuticals Plc
Ticker
HEMO
Listing
LSE
Country or territory
United Kingdom
Business scope
Biotechnology
ISIN
GB00BQVXM815
Other listed symbols
LSX:A40WGA
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.